On June 7th, the Psychiatric Times featured an article by Kenneth Bender titled, "Investigational Antipsychotic Demonstrates Efficacy Without Blocking Dopamine Receptor." David Walling, PhD, Chief Clinical Officer of CenExel CNS, was highlighted as a Principal Investigator in the study. To read the article, click here: https://lnkd.in/dn29dNuZ. Congratulations, Dr. Walling! www.cenexel.com #CenExel #InTheNews #ClinicalResearch
CenExel’s Post
More Relevant Posts
-
Join our international panel of experts to learn more about how to treat your patients who suffer from Tinnitus with topics like current best practices, tinnitus & comorbidities and the use of Cognitive Behavioral Therapy (CBT) treatment.
Our Virtual Physician Symposium on Tinnitus is just a couple of weeks away! Register today at https://hubs.la/Q021l4K60 Join our international panel of experts to learn more about how to treat your patients who suffer from Tinnitus with topics like current best practices, tinnitus & comorbidities and the use of Cognitive Behavioral Therapy (CBT) treatment. Event Time & Date: Wednesday, September 27th, 2023, 12:30pm - 2:00pm EST
To view or add a comment, sign in
-
-
Dive into the future of healthcare with our latest chat with Sam Clark, MD PhD of Terran Biosciences at the Wonderland Conference end of 2023! Discover how they're breaking the mold in neuropsychiatric treatment with a blend of innovation and agility. Watch Now #HealthInnovation #TerranBiosciences
Terran CEO and Founder, Sam Clark, MD PhD sat down with Reed Berglund from Breathe Media Network to discuss Terran's groundbreaking work within the mental health and neurodegenerative spaces. Dr. Clark talked about Terran’s success in reviving a small molecule treatment that had shown promising efficacy in schizophrenia and making it a once-daily pill that is currently in clinical testing. Another topic of discussion was the future of Parkinson’s disease, including current diagnostic options, the promise of neuromelanin MRI, and Terran’s NM-101, an FDA-cleared, cloud-based system to analyze neuromelanin MRI. Watch the full interview here: https://bit.ly/3ONxz7x #neurodegenerativedisease #neuromelanin #Parkinsonsdisease #MRI #MedEd
To view or add a comment, sign in
-
Advice to tinnitus patients: Four behavioral methods of treatment are supported by research and by many years of clinical implementation. These methods include cognitive behavioral therapy, Tinnitus Retraining Therapy, Tinnitus Activities Treatment, and Progressive Tinnitus Management. If none of these methods is received can a person still find relief from the effects of tinnitus? Absolutely! No one method has been proven to be any more effective than any other method. Keys to living a normal life in spite of tinnitus are to become informed about all aspects of tinnitus, learn how sound therapy can be helpful for you, be skeptical of any product or service that is unproven and/or expensive, and try to meet with a clinician who is knowledgeable and competent in providing tinnitus services and who has your best interest in mind.
To view or add a comment, sign in
-
📔Read the new paper about #BorderlinePersonalityDisorder #therapy! #psychiatry #MentalHealth #BPD #neuroscience #research #brain MDPI Scilit
Short- and Long-Term Outcomes of an Adventure Therapy Programme on Borderline Personality Disorder: A Pragmatic Controlled Clinical Trial 👉 https://mdpi.com/2697110 via Brain Sciences MDPI
To view or add a comment, sign in
-
-
✨ Compelling additional data documenting the efficacy of evenamide in our phase II/III study in poorly responding schizophrenia patients🔬 💊 A further analysis of our study reveals significant multi-domain benefits in PANSS and Clinical Global Impression of Change. Also,the benefit of the efficacy measures increased over time, suggesting larger and enduring patient effects to be expected during long-term treatment. "These findings, along with those noted in study 014/015, where patients with treatment-resistant schizophrenia treated with evenamide for one year experienced progressive, sustained and long-lasting clinically significant benefits, further highlight the growing importance of glutamate modulation for the development of novel treatments for patients with schizophrenia", explained our Chief Medical Officer, Ravi Anand. Read more: https://lnkd.in/epJ8CJcj #Newron #NovelTherapies #results #evenamide #schizophrenia
To view or add a comment, sign in
-
-
🌟 Exciting News: Psychedelic Therapy Resurgence 🍄💊 After a six-decade hiatus, experimental psychedelic therapy is making a powerful comeback at the Department of Veterans Affairs. Clinical trials using MDMA and psilocybin mushrooms are reigniting research abandoned in the 1960s, changing the way we view these substances. At least five trials are underway, led by government clinicians who are eager to explore the therapeutic potential of psychedelics in conjunction with psychotherapy. The primary focus is on conditions that affect veterans, such as post-traumatic stress disorder (PTSD) and substance abuse. "This is a monumental moment," says Dr. Rachel Yehuda, who is leading one of the studies at the James J. Peters Veterans Affairs Medical Center in the Bronx. The goal is to offer hope through safe, guided psychedelic experiences that disrupt harmful thought patterns and behaviors. 🚀 #PsychedelicResearch #VeteransHealth #HopefulTrials #MentalHealthRevolution
To view or add a comment, sign in
-
-
Our freshly published paper in *Cells* https://lnkd.in/dT2VAhsA from a study exploring kynurenine pathway in schizophrenia patients showed *Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients*. Key findings from our study are decreased KYN and KYNA concentrations in the plasma in schizophrenia patients irrespective of illness state, type of antipsychotic treatment, number of episodes or illness duration and no differences in the KYN/TRP ratio between schizophrenia patients and healthy individuals. These findings could be interpreted as indices that the kynurenine pathway might not be dysregulated in the periphery and that other factors contribute to observed disturbances in concentrations. However, as our study had certain limitations, we cannot draw definite conclusions. #research #schizophrenia #kynurenine
To view or add a comment, sign in
-
-
Violence is a multifactorial and socially as well as psychologically, neuropsychologically and neurologically driven behavior. Qualified experts in the field assist judges, juries and attorneys to understand the relationship between violence and mental illness and the brain. The Forensic Neuropsychological and Neurological Evaluation of Violence chapter, authored by John Matthew Fabian, Psy.D., J.D., A.B.P.P., provides an in-depth examination of the field, including the literature of brain structure and function, mental illness and neurobiological disorders vis-à-vis violence, as well as how the issues are evaluated by professionals in this unique area of expertise. https://lnkd.in/gbpUn62H
Forensic Neuropsychological and Neurological Evaluation of Violence — Demosthenes Lorandos, Ph.D., J.D.
drlorandos.net
To view or add a comment, sign in